CombiMatrix Corporation to Release 2017 First Quarter Financial Results on May 4, 2017
27 avr. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., April 27, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
01 mars 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., March 01, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
22 févr. 2017 16h05 HE
|
CombiMatrix Corporation
Achieves record quarterly reproductive health revenues and test volume, across-the-board increases in average revenue per test, expanded gross margin, significantly narrowed operating loss and record...
CombiMatrix Corporation to Release 2016 Fourth Quarter and Full Year Financial Results on February 22, 2017
15 févr. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix to Present at 2nd Annual Disruptive Growth & Healthcare Conference
08 févr. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
02 févr. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Feb. 02, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
20 janv. 2017 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Jan. 20, 2017 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix’s Pre-Implantation Genetic Screening by Next Generation Sequencing Granted Conditional Approval from New York State Department of Health
29 nov. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Nov. 29, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric...
CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results
02 nov. 2016 06h00 HE
|
CombiMatrix Corporation
Rapidly growing revenue, increasing test volume, gross margin expansion, strong cash reimbursement and prudent expense management provide clear path to profitability Conference call begins today...
CombiMatrix Corporation to Release 2016 Third Quarter Financial Results on November 2, 2016
26 oct. 2016 06h00 HE
|
CombiMatrix Corporation
IRVINE, Calif., Oct. 26, 2016 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NASDAQ:CBMX) announces that it will release financial results for the three and nine months ended September 30, 2016 after...